- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 39-53 of
300 results
2041 Exhibit: Renier J Brentjens et al, Genetically Targeted T Cells Eradicate Syste...
Document
IPR2022-00855, No. 2041-87 Exhibit - Renier J Brentjens et al, Genetically Targeted T Cells Eradicate Systemic Acute Lymphoblastic Leukemia Xenografts, 13 CLINICAL CANCER RSCH 5426 2...
|
|
Cite Document
2011 Exhibit: Brian G Till et al, Adoptive immunotherapy for indolent non Hodgkin ly...
Document
IPR2022-00855, No. 2011-57 Exhibit - Brian G Till et al, Adoptive immunotherapy for indolent non Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20 spec...
|
|
Cite Document
2022 Exhibit: Holly Auer, Penn Medicine Immunotherapy Pioneer Carl June, MD, A...
Document
IPR2022-00855, No. 2022-68 Exhibit - Holly Auer, Penn Medicine Immunotherapy Pioneer Carl June, MD, Awarded 2015 Paul Ehrlich and Ludwig Darmstaedter Prize, PENN TODAY Mar 11, 201...
|
|
Cite Document
2002 Exhibit: Denise Grady, An Immune System Trained to Kill Cancer, NY TIMES S...
Document
IPR2022-00855, No. 2002-48 Exhibit - Denise Grady, An Immune System Trained to Kill Cancer, NY TIMES Sept 12, 2011, httpswwwnytimescom20110913health13genehtml (P.T.A.B. Jul. 19, 20...
|
|
Cite Document
2016 Exhibit: Jennifer Couzin Frankel, Breakthrough of the Year 2013 Cancer Imm...
Document
IPR2022-00855, No. 2016-62 Exhibit - Jennifer Couzin Frankel, Breakthrough of the Year 2013 Cancer Immunotherapy, 342 SCI 1432 2013 (P.T.A.B. Jul. 19, 2022)
|
|
Cite Document
2013 Exhibit: Renier Brentjens et al, Treatment of chronic lymphocytic leukemia wit...
Document
IPR2022-00855, No. 2013-59 Exhibit - Renier Brentjens et al, Treatment of chronic lymphocytic leukemia with genetically targeted autologous T cells case report of an unforeseen adverse event ...
|
|
Cite Document
2006 Exhibit: Denise Grady, FDA Approves First Gene Altering Leukemia Treatmen...
Document
IPR2022-00855, No. 2006-52 Exhibit - Denise Grady, FDA Approves First Gene Altering Leukemia Treatment, Costing $475,000, NY TIMES Aug 30, 2017, httpswwwnytimescom20170830health...
|
|
Cite Document
2025 Exhibit: Agilent Presents Thought Leader Award to Drs Carl H June and Micha...
Document
IPR2022-00855, No. 2025-71 Exhibit - Agilent Presents Thought Leader Award to Drs Carl H June and Michael Milone, AGILENT TECHS INC Nov 17, 2020, httpswwwagilentcomaboutnewsroomp...
|
|
Cite Document
2035 Exhibit: Grazyna Lipowska Bhalla, Targeted immunotherapy of cancer with CA...
Document
IPR2022-00855, No. 2035-81 Exhibit - Grazyna Lipowska Bhalla, Targeted immunotherapy of cancer with CAR T cells achievements and challenges, 61 CANCER IMMUNOLOGY, IMMUNOTHER...
|
|
Cite Document
2033 Exhibit: Richard A Morgan et al, Case Report of a Serious Adverse Event Follo...
Document
IPR2022-00855, No. 2033-79 Exhibit - Richard A Morgan et al, Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Reco...
|
|
Cite Document
2018 Exhibit: David L Porter et al, Randomized, Phase II Dose Optimization Study O...
Document
IPR2022-00855, No. 2018-64 Exhibit - David L Porter et al, Randomized, Phase II Dose Optimization Study Of Chimeric Antigen Receptor Modified T Cells Directed Against CD 19 CTL019 In Patie...
|
|
Cite Document
2029 Exhibit: Pilot Study for Patients with Chemotherapy Resistant or Refractory C...
Document
IPR2022-00855, No. 2029-75 Exhibit - Pilot Study for Patients with Chemotherapy Resistant or Refractory CD19 Leukemia and Lymphoma CART 19, CLINICALTRIALSGOV April 29, 2009, httpwe...
|
|
Cite Document
2042 Exhibit: US Patent No 7,402,431
Document
IPR2022-00855, No. 2042-88 Exhibit - US Patent No 7,402,431 (P.T.A.B. Jul. 19, 2022)
|
|
Cite Document
2041 Exhibit: Renier J Brentjens et al, Genetically Targeted T Cells Eradicate Syste...
Document
IPR2022-00855, No. 2041-87 Exhibit - Renier J Brentjens et al, Genetically Targeted T Cells Eradicate Systemic Acute Lymphoblastic Leukemia Xenografts, 13 CLINICAL CANCER RSCH 5426 2...
|
|
Cite Document
2033 Exhibit: Richard A Morgan et al, Case Report of a Serious Adverse Event Follo...
Document
IPR2022-00855, No. 2033-79 Exhibit - Richard A Morgan et al, Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Reco...
|
|
Cite Document
